By the same authors

From the same journal

FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells

Research output: Contribution to journalArticle


  • F Ropiquet
  • S Huguenin
  • J M Villette
  • V Ronfle
  • G Le Brun
  • N J Maitland
  • O Cussenot
  • J Fiet
  • P Berthon


Publication details

JournalInternational Journal of Cancer
DatePublished - 19 Jul 1999
Issue number2
Number of pages7
Pages (from-to)237-243
Original languageEnglish


Fibroblast growth factor 7 (FGF7/KGF) is synthesized exclusively by fibroblasts in normal tissues; it acts as a potent mitogen on epithelial cells, through interaction with the FGF7-specific receptor FGFR2/IIIb. To examine the importance of this growth factor both to prostate physiology and to prostate cancer progression, we have tested the exogenous effect of FGF7. Thus, by mimicking the paracrine pathway (on proliferation, growth in soft agar and invasion) on the human prostatic epithelial cell line PNTIA positively checked for FGFR2/IIIb expression, FGF7 significantly enhanced cell proliferation at an optimal concentration of 7.5 x 10(-11) M, but no significant invasion or growth in soft agar were observed. To confirm FGF7 properties on human prostatic epithelial cells, we constitutively expressed FGF7 by transfecting PNT1A cells with FGF7-cDNA. The FGF7-transfected clones, PNT1A/ FGF7-T5 and FNT1A/FGF7-T6, were stable and expressed FGF7. Analysis of the FGF7-autocrine loop on the nontumorigenic epithelial cells PNTIA showed acquired invasive potential in in vitro extracellular-matrix migration assays, specifically inhibited by an FGF7-neutralizing antibody, and over-expressed factors implicated in the migration process: the metalloproteinase MMP-1 and the plasminogen activator uPA. Taken together, these results demonstrate a role for FGF7 in triggering invasion of human prostatic epithelial cells. Furthermore, these FGF7-transfected clones exhibited functional and physiological differences from the original PNT1A cell line: anchorage-independent growth, growth in serum-free media and increased proliferation. These data confirm the oncogenic function of FGF7 in prostate progression potentially acting through paracrine and/or autocrine regulatory pathways. (C) 1999 Wiley-Liss, Inc.

    Research areas


Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations